Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Grant revenues	$ 295,735	$ 47,600
Operating expenses:
Research and development	551,795	438,004
General and administrative	292,667	906,505
Total operating expenses	844,462	1,344,509
Loss from operations	(548,727)	(1,296,909)
Other income:
Interest income	386	630
Total other income	386	630
Net loss	$ (548,341)	$ (1,296,279)
Basic and diluted:
Loss per common share (in dollars per share)	$ (0.01)	$ (0.04)
Weighted average shares outstanding (in shares)	55,350,974	34,599,625